Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.159 HKD | +2.58% | +1.92% | +41.96% |
02-23 | Aceso Life Science Group Limited Announces Resignation of Xu Haiying as Executive Director | CI |
2023 | Aceso Life Science's Loss Widens in Fiscal H1 | MT |
Sales 2022 | 170M 21.72M 1.74B | Sales 2023 | 207M 26.44M 2.12B | Capitalization | 1.31B 168M 13.44B |
---|---|---|---|---|---|
Net income 2022 | -370M -47.26M -3.78B | Net income 2023 | -264M -33.72M -2.7B | EV / Sales 2022 | 16.3 x |
Net Debt 2022 | 2.29B 293M 23.45B | Net Debt 2023 | 2.32B 296M 23.73B | EV / Sales 2023 | 17.6 x |
P/E ratio 2022 |
-1.15
x | P/E ratio 2023 |
-4.93
x | Employees | 142 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 29.32% |
1 day | +2.58% | ||
1 week | +1.92% | ||
3 months | +3.92% | ||
6 months | +2.58% | ||
Current year | +41.96% |
Managers | Title | Age | Since |
---|---|---|---|
Chi Tak Fok
DFI | Director of Finance/CFO | 48 | 15/12/10 |
Chun Pong Siu
SEC | Corporate Secretary | 44 | 25/08/22 |
Lai Ping Chan
LAW | General Counsel | 40 | 31/08/13 |
Members of the board | Title | Age | Since |
---|---|---|---|
Kwan Sing Lam
BRD | Director/Board Member | 54 | 08/08/12 |
Ming Sun Chan
BRD | Director/Board Member | 51 | 28/03/12 |
Chi Tak Fok
DFI | Director of Finance/CFO | 48 | 15/12/10 |
Date | Price | Change | Volume |
---|---|---|---|
26/04/24 | 0.159 | +2.58% | 24,000 |
25/04/24 | 0.155 | -2.52% | 498,400 |
24/04/24 | 0.159 | +2.58% | 104,000 |
23/04/24 | 0.155 | 0.00% | 0 |
22/04/24 | 0.155 | -0.64% | 0 |
Delayed Quote Hong Kong S.E., April 26, 2024 at 09:08 am
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+41.96% | 150M | |
+3.88% | 9.29B | |
+11.54% | 7.78B | |
-28.00% | 1.55B | |
+9.61% | 872M | |
+13.12% | 542M | |
-21.40% | 510M | |
-1.81% | 493M | |
+12.09% | 312M | |
-16.02% | 284M |
- Stock Market
- Equities
- 474 Stock